| 招股日期 | 2021/08/10 - 2021/08/13 | | 定价日期 | 2021/08/13 | | 公布售股结果日期 | 2021/08/19 | | 退票寄发日期 | 2021/08/19 | | 上市日期 | 2021/08/20 | | | |
| |
| |
| 名称 | 类别 | 总额 | | 3W Fund Management Limited | 基金 | 美元3百万 | | Aspex Master Fund | 基金 | 美元10百万 | | Boyu Capital Opportunities Master Fund | 基金 | 美元10百万 | | Goldstream Capital Segregated Portfolio Company - Goldstream Healthcare Focus Fund SP | 基金 | 美元3百万 | | Lake Bleu Prime Healthcare Master Fund Limited | 基金 | 美元10百万 | | LYFE CAPITAL FUND III (DRAGON), L.P. | 基金 | 美元5百万 | | Octagon Investments Master Fund LP | 基金 | 美元10百万 | | Sage Partners Master Fund | 基金 | 美元5百万 | | Superstring Capital Master Fund LP | 基金 | 美元5百万 | | The Valliance Fund | 基金 | 美元5百万 | |
| 公司名称 | 现价2 | 今日升跌 | 十日升跌 | 市盈率 | 市值(亿) | 相关资料 | | 微创机器人-B | 26.680 | +25.849% | +28.89% | N/A | 273.40亿 | | | 归创通桥 | 23.100 | +3.309% | +5.00% | 70.04 | 76.12亿 | | | 微创心通-B | 1.040 | +5.051% | -11.11% | N/A | 66.21亿 | | | 先瑞达医疗-B | 14.200 | +2.158% | +6.77% | 76.88 | 44.50亿 | | | 沛嘉医疗-B | 6.410 | 0.000% | +10.33% | N/A | 43.04亿 | | | 健世科技-B | 9.220 | +0.217% | +6.22% | N/A | 28.61亿 | | | 百心安-B | 5.540 | -2.977% | -6.42% | N/A | 13.06亿 | | | 微泰医疗-B | 7.720 | +0.521% | +13.36% | N/A | 12.82亿 | | | 鹰瞳科技-B | 11.950 | -0.417% | +5.75% | N/A | 12.25亿 | | | (坤)博医疗-B | 2.280 | +1.333% | -6.56% | N/A | 12.01亿 | | |
| |
| |
| |